Rebecca L Ball,1 Palak Bajaj,1,2 Kathryn A Whitehead1,2 1Department of Chemical Engineering, 2Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA, USA Abstract: The broadest clinical application of siRNA therapeutics will be facilitated by drug-loaded delivery systems that maintain stability and potency for long times under ambient conditions. In the present study, we seek to better understand the stability and effect of storage conditions on lipidoid nanoparticles (LNPs), which have been previously shown by our group and others to potently deliver RNA to various cell and organ targets both in vitro and in vivo. Specifically, this study evaluates the influence of pH, temperature, and lyophilization on LNP effi...
Recently, bioinspired cell-derived nanovesicles (CDNs) have gained much interest in the field of nan...
A drawback of the current mRNA-lipid nanoparticle (LNP) COVID-19 vaccines is that they have to be st...
A drawback of the current mRNA-lipid nanoparticle (LNP) COVID-19 vaccines is that they have to be st...
Lipid nanoparticles (LNPs) are currently in the spotlight as delivery systems for mRNA therapeutics ...
Liposomes are versatile and well-proven as a means to deliver nucleic acids into cells. Most of the ...
Liposomes are versatile and well-proven as a means to deliver nucleic acids into cells. Most of the ...
Worapol Ngamcherdtrakul,1,2,* Thanapon Sangvanich,1,* Moataz Reda,1 Shenda Gu,1 Daniel Bejan,2 Wassa...
In an ideal world, pharmaceutical drugs would have infinite shelf life, no susceptibility to degrada...
Lipid nanoparticles (LNPs) are emerging new modalities for mRNA therapeutics which have been in the ...
We designed a novel lyophilization method using controlled rate slow freezing (CSF) with lyoprotecti...
A drawback of the current mRNA-lipid nanoparticle (LNP) COVID-19 vaccines is that they have to be st...
WOS: 000423282700020The development of optimized plasmid DNA delivery systems is necessary to delive...
Nucleic acid therapies have the potential to enable the treatment of disorders previously untreatabl...
Objective: Aim of the present study was to formulate solid lipid nanoparticles (SLNs) and to determi...
Recently, bioinspired cell-derived nanovesicles (CDNs) have gained much interest in the field of nan...
Recently, bioinspired cell-derived nanovesicles (CDNs) have gained much interest in the field of nan...
A drawback of the current mRNA-lipid nanoparticle (LNP) COVID-19 vaccines is that they have to be st...
A drawback of the current mRNA-lipid nanoparticle (LNP) COVID-19 vaccines is that they have to be st...
Lipid nanoparticles (LNPs) are currently in the spotlight as delivery systems for mRNA therapeutics ...
Liposomes are versatile and well-proven as a means to deliver nucleic acids into cells. Most of the ...
Liposomes are versatile and well-proven as a means to deliver nucleic acids into cells. Most of the ...
Worapol Ngamcherdtrakul,1,2,* Thanapon Sangvanich,1,* Moataz Reda,1 Shenda Gu,1 Daniel Bejan,2 Wassa...
In an ideal world, pharmaceutical drugs would have infinite shelf life, no susceptibility to degrada...
Lipid nanoparticles (LNPs) are emerging new modalities for mRNA therapeutics which have been in the ...
We designed a novel lyophilization method using controlled rate slow freezing (CSF) with lyoprotecti...
A drawback of the current mRNA-lipid nanoparticle (LNP) COVID-19 vaccines is that they have to be st...
WOS: 000423282700020The development of optimized plasmid DNA delivery systems is necessary to delive...
Nucleic acid therapies have the potential to enable the treatment of disorders previously untreatabl...
Objective: Aim of the present study was to formulate solid lipid nanoparticles (SLNs) and to determi...
Recently, bioinspired cell-derived nanovesicles (CDNs) have gained much interest in the field of nan...
Recently, bioinspired cell-derived nanovesicles (CDNs) have gained much interest in the field of nan...
A drawback of the current mRNA-lipid nanoparticle (LNP) COVID-19 vaccines is that they have to be st...
A drawback of the current mRNA-lipid nanoparticle (LNP) COVID-19 vaccines is that they have to be st...